Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

A renowned company best known for its brain implants has made headway towards more applications for its latest design, with Synchron announcing its milestones for the Stentrode device. The company ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Synchron has reported that its miniature brain-computer interface implant, threaded up through the blood vessels to help read the activity of the motor cortex, showed no major side effects in a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Interim results from the COMMAND study evaluating the ...

Synchron has developed a minimally invasive brain-computer interface capable of controlling devices like Apple Vision Pro, and it has reached the one-year milestone without serious adverse effects to ...

Mark Jackson, who lives with ALS, received Synchron's Stentrode system brain-computer interface (BCI) implant in August 2023. In the video, Jackson says that he wants to use whatever time he has left ...

These are exciting times at the intersection of artificial intelligence (AI) and neuroscience. The trend in brain-computer interfaces (BCIs) is toward flexible and less invasive devices that can ...

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...

Apple's research into future technology usage has led to an ALS patient controlling an Apple Vision Pro with their mind, using an implant. While Apple products can be controlled by many different ...